Ironwood Pharmaceuticals (IRWD) Other Operating Expenses (2012 - 2023)

Ironwood Pharmaceuticals (IRWD) has 10 years of Other Operating Expenses data on file, last reported at $5.0 million in Q4 2023.

• For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Sep 2024 stood at $5.0 million (down 99.55% YoY), and the FY2023 full-year result was $1.1 billion, changed N/A from the prior year.
• Other Operating Expenses retreated to $5.0 million in Q4 2023, from $1.1 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.1 billion in Q2 2023 to a low of -$3.0 million in Q3 2019.
• A 3-year average of $143.0 million and a median of $3.6 million in 2020 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 110.73% in 2019, while the deepest fall reached 102.47% in 2019.
• Tracing IRWD's Other Operating Expenses over 3 years: stood at $11.0 million in 2019, then tumbled by 91.86% to $897000.0 in 2020, then surged by 457.41% to $5.0 million in 2023.
• Business Quant data shows IRWD's Other Operating Expenses at $5.0 million in Q4 2023, $1.1 billion in Q2 2023, and $897000.0 in Q4 2020.